Lidia Larrañaga. Qualified person / Regulatory affairs.
Ander Larrañaga. General Manager/ Business Development.
Giuseppe Tomasi Scianó.
At LITAPHAR we work on research into new indications that provide therapeutic solutions for illnesses related to women. Most of them not tackled until now.
More specifically, we have been researching for 12 years into different applications in gynaecology and obstetrics of prostaglandin analogues, progesterone receptor antagonists and selective modulators of progesterone receptors.
The Projects we are currently developing are:
- Uterine Fibroid
- Postpartum Hemorrhage
- Dysfunctional Uterine Hemorrhages
- Labour Induction
- Cervix Dilation
- Voluntary Termination of Pregnancy
- Emergency Contraception
At LITAPHAR we are a reference in the research into the health and quality of life of women and more specifically into sexuality and vulvar health.
We were pioneers examining different products for the female sexual dysfunctions based on L-Arginine.
In addition to products for vulvar hygiene and daily care, at LITAPHAR we never forget that good sexual health is based on good vaginal health and for this reason we create solutions for the following pathologies:
- Atrophic vulvitis